Trials / Completed
CompletedNCT06515054
Isometric Exercise for Hypertension
Effectiveness and Mechanisms of Isometric Resistance Exercise to Reduce Blood Pressure in a Chinese Population: a Pilot Randomized-controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Chinese University of Hong Kong · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Background: Isometric resistance exercises (IREs) have great potential to improve blood pressure (BP) control. Methods: This is a pilot randomized controlled trial that will involve 50 patients with hypertension (HT) who do not meet the current physical activity guidelines defined by the World Health Organization. Participants will be randomly assigned in a 1:1 ratio using stratified and blocked randomization to either the IRE (wall squat) group or stretching exercise (active control) group. A well-structured, widely accepted, and validated 24-week wall squat program (2 minutes per exercise, 2 minutes of rest between sets, and 3 sessions per week) will be implemented, as it has been commonly used in previous research. All patients will be followed up for 24 weeks. Control group will receive exact same treatment except that IRE is replaced by frequency-matched and time-matched stretching exercise. The primary outcome measure will be rate of recruitment. Secondary outcomes will include BP parameters from 24-hour ambulatory BP monitoring
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | wall squat | self-learnt wall squat exercise to be conducted for totally 24 weeks |
| BEHAVIORAL | passive stretching | time-matched passive stretching exercise to be conducted for totally 24 weeks |
Timeline
- Start date
- 2024-07-20
- Primary completion
- 2025-09-30
- Completion
- 2025-11-30
- First posted
- 2024-07-23
- Last updated
- 2025-12-16
Locations
1 site across 1 country: Hong Kong
Source: ClinicalTrials.gov record NCT06515054. Inclusion in this directory is not an endorsement.